Amyloid-β (phospho Thr743) Polyclonal Antibody

Alias:APP;A4;AD1;Amyloid beta A4 protein;ABPP;APPI;APP;Alzheimer disease amyloid protein;Cerebral vascular amyloid peptide;CVAP;PreA4;Protease nexin-II;PN-II

CatalogNo:HJRLP0855

Specifications

50μL;100μL

Delivery date

Spot

Target

Amyloid-β

Reactivity

Human,Mouse,Rat

Application - After Update

WB,IHC,IF,ELISA

MW(Observed)

140kD

Host Species

Rabbit

Isotype

IgG

Modify

Phospho

Recommended dilution ratio

WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:10000;Not yet tested in other applications.

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human Amyloid beta A4 around the phosphorylation site of Thr743/668. AA range:711-760

Specificity

Phospho-Amyloid-β (T743) Polyclonal Antibody detects endogenous levels of Amyloid-β protein only when phosphorylated at T743.

Gene name

APP

Protein name

Amyloid beta A4 protein, Amyloid-β, Aβ

Organism-1

Human